Search

everythinglearnresearchcommunity

for

Search:↓

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Genetic testing for cancer risk can lead to early and life-saving treatments in people without symptoms.

Chemotherapy significantly lowers Inhibin A levels in breast cancer patients.

Targeting colon cancer stem cells might lead to better treatment results.

Notch signalling helps skin cells differentiate and prevents tumors.

ERG increases SOX9, promoting prostate cancer growth and invasion.

Colorectal cancer development involves both genetic changes and epigenetic alterations like DNA methylation and microRNA changes.

Prostate cancer was a major health issue in 2009, especially for Black men, and targeting the 5alpha-reductase enzyme could help in its prevention and treatment.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Older adults have a high rate of skin cancers like basal cell carcinoma and melanoma, mainly due to UV exposure and age.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Selenium and vitamin E supplements have mixed effects on prostate cancer risk and may not be beneficial for everyone.

The Hedgehog signaling pathway is important for skin and hair growth and can lead to cancer if it doesn't work right.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Vitamin D receptor may help protect against UV-induced skin cancer.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.